LINGOOD
833284
HENDERA
831152
Hanjia Design Group
300746
4
Guangdong Real-Design Intelligent Technology
301135
5
Fuxin Dare Automotive Parts
300473
Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.